News
The Physical and Emotional Symptoms of a PTSD Attack: What to Look Out For
When someone experiences or witnesses a traumatic event, it can have lasting effects. People with post-traumatic stress disorder (PTSD) will often relive the event or aspects of it long after it has passed, experiencing intense PTSD attack symptoms both...
IT & Data Management
Patient-Centred Approach Creating Space In Pharmaceuticals
Apparently, pharmaceutical industry happens to be going through a prominent shift towards patient-centric approaches, thereby recognizing the significance of considering patient perspectives right across drug development as well as the healthcare delivery process. This shift happens to be driven...
IT & Data Management
Pharma Companies May Gain From Digital Health Investor Plans
It is worth noting that this year happened to be one of contraction within the digital health space, beginning with a new normal investment climate that involved fewer deals, reduced check sizes, and a smaller group of sector investors,...
News
Pharma Challenge In Singapore – Making The Most of The Flow
It is worth noting that Singapore may still be waiting for its first biotech bellwether, but it has for sure turned a corner in the eyes of many across the West. An advent of investor interest as well as...
News
10 Vital Strategies For Building Healthcare Infrastructure
It is well to be noted that building sustainable as well as resilient healthcare facilities across Asia happens to be a complex urge that requires a holistic along with an integrated approach. Let us dive into ten crucial strategies...
News
Etihad Cargo continues strong cool chain product growth trajectory
Etihad Cargo, the cargo and logistics arm of Etihad Airways, achieved year-on-year growth of the carrier's dedicated cool chain products — PharmaLife and FreshForward — in 2023. The airline recorded the highest volumes of pharmaceuticals transported in Etihad Cargo's...
News
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance’s AMTAGVI for Advanced Melanoma
WuXi Advanced Therapies , a wholly owned subsidiary of WuXi AppTec announced that the U.S. FDA has approved its Philadelphia site to begin the analytical testing and manufacturing of AMTAGVI for Iovance, which received FDA accelerated approval of its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read